NCT04169789View on ClinicalTrials.gov

Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri

NACompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

December 4, 2019

Primary Completion Date

October 18, 2022

Study Completion Date

October 18, 2022

Conditions
Postmenopausal Osteoporosis
Interventions
DIETARY_SUPPLEMENT

Lactobacillus reuteri ATCC PTA 6475 (L. reuteri 6475)

L.reuteri high or low dose with cholecalciferol compared to cholecalciferol only.

Trial Locations (1)

43180

Geriatric Medicine, Sahlgrenska University Hospital, Mölndal, Gothenburg

Sponsors

Collaborators (1)

BioGaia AB
All Listed Sponsors
collaborator

BioGaia AB

INDUSTRY

lead

Sahlgrenska University Hospital

OTHER

NCT04169789 - Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri | Biotech Hunter | Biotech Hunter